PSA Small-Caps: CUC (9158 JT) FY24 Q2 Results Comment
Specialized hospice provider CUC (9158 JT) announced better than expected FY24 Q2 results and yet has not revised up for the full year. Analyst Hiroyuki Terada explains the reasons why and notes he will review the outlook after his scheduled meeting with management on 5 Nov..
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.